Skip to main content
Erschienen in: Gastric Cancer 3/2015

01.07.2015 | Original Article

Randomized controlled trial comparing gastric cancer screening by gastrointestinal X-ray with serology for Helicobacter pylori and pepsinogens followed by gastrointestinal endoscopy

verfasst von: Takuji Gotoda, Hideki Ishikawa, Hirohide Ohnishi, Kentaro Sugano, Chika Kusano, Chizu Yokoi, Yutaka Matsuyama, Fuminori Moriyasu

Erschienen in: Gastric Cancer | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Based on the results of several case–control and cohort studies gastrointestinal X-ray (GI X-ray) has been recommended for use in the nationwide screening program for gastric cancer.. Although this was the only effective screening program when almost all of the Japanese population were Helicobacter pylori (H. pylori) positive, there has been concern whether an alternative effective screening system should be established for the future H. pylori-negative generation. We therefore conducted the first randomized controlled trial (RCT) comparing GI X-ray and gastrointestinal endoscopy (GIE) scheduled according to results of serological testing (ST); this was done to determine the potential for an alternative screening method.

Methods

Subjects who fulfilled the inclusion criteria were residents between the ages of 30 and 74 and who were able to receive gastric cancer screening in the Yurihonjo area. Participants were assigned to the GI X-ray group or the GIE-ST group by computer randomization. Subjects in each group were further subdivided into 4 categories according to their different risks for gastric cancer. The feasibility of stratified randomization was serologically assessed and detection rates of gastric cancer at entry by the different screening methods were also compared.

Results

Of the 2,962 subjects invited, 1,206 individuals (41 percent) were included in the first stage of this stratified RCT, and 604 and 602 individuals were assigned to the GI X-ray group and the GIE-ST group, respectively. There were no statistically significant differences in sex, age, height, body weight, smoking, alcohol intake and family history of cancer between the 2 groups. During ST the GI X-ray group showed a distribution that was not statistically different from that of the GIE-ST group. Although 3 cases of gastric cancer were detected in the GIE-ST group, there was no statistically significant difference between the 2 groups. One complication found was barium aspiration during the examination in the X-ray group.

Conclusion

We confirmed that baseline demographic features of the 2 groups were well balanced. We are now organizing the first RCT to compare the existing screening method and the alternative method (Clinical trial registration number: UMIN000005962).
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.PubMedCrossRef Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.PubMedCrossRef
2.
Zurück zum Zitat Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5, version 2.0. Lyon: IARC Press, 2004. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5, version 2.0. Lyon: IARC Press, 2004.
5.
Zurück zum Zitat Hisamichi Y, Nishino Y, Hisamichi S. Screening for gastric cancer. World J Surg. 1989;13:31–7.PubMedCrossRef Hisamichi Y, Nishino Y, Hisamichi S. Screening for gastric cancer. World J Surg. 1989;13:31–7.PubMedCrossRef
6.
Zurück zum Zitat Tsubono Y, Nishino Y, Hisamichi S. Screening for gastric cancer in Miyagi, Japan: evaluation with a population-based cancer registry. Asian Pac J Cancer Prev. 2000;1:57–60.PubMed Tsubono Y, Nishino Y, Hisamichi S. Screening for gastric cancer in Miyagi, Japan: evaluation with a population-based cancer registry. Asian Pac J Cancer Prev. 2000;1:57–60.PubMed
7.
Zurück zum Zitat Shiratori Y, Nakagawa S, Kikuchi A, Ishii M, Ueno M, Miyashita T, et al. Significance of a gastric mass screening survey. Am J Gastroenterol. 1985;80:831–4.PubMed Shiratori Y, Nakagawa S, Kikuchi A, Ishii M, Ueno M, Miyashita T, et al. Significance of a gastric mass screening survey. Am J Gastroenterol. 1985;80:831–4.PubMed
8.
Zurück zum Zitat Tsubono Y, Nishino Y, Hisamichi S. Screening for gastric cancer in Japan. Gastric Cancer. 2000;3:9–18.PubMedCrossRef Tsubono Y, Nishino Y, Hisamichi S. Screening for gastric cancer in Japan. Gastric Cancer. 2000;3:9–18.PubMedCrossRef
9.
Zurück zum Zitat Hamashima C, Shibuya D, Yamazaki H, Inoue K, Fukao A, Saito H, et al. The Japanese guideline for gastric cancer screening. Jpn J Clin Oncol. 2008;38:259–67.PubMedCrossRef Hamashima C, Shibuya D, Yamazaki H, Inoue K, Fukao A, Saito H, et al. The Japanese guideline for gastric cancer screening. Jpn J Clin Oncol. 2008;38:259–67.PubMedCrossRef
10.
Zurück zum Zitat Sobue T, Fukao A, Tsuji I, Ohnuki K, Sagawa M, Aoki D, et al. The Japanese Research Group for Development of Cancer Screening Guideline. Japanese guideline for gastric (stomach) cancer screening. (In Japanese). Tokyo: The Japanese Ministry of Health, Labour and Welfare; 2006. Sobue T, Fukao A, Tsuji I, Ohnuki K, Sagawa M, Aoki D, et al. The Japanese Research Group for Development of Cancer Screening Guideline. Japanese guideline for gastric (stomach) cancer screening. (In Japanese). Tokyo: The Japanese Ministry of Health, Labour and Welfare; 2006.
11.
Zurück zum Zitat Personnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991;325:1127–31.CrossRef Personnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991;325:1127–31.CrossRef
12.
Zurück zum Zitat Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese American in Hawaii. N Engl J Med. 1991;325:1132–6.PubMedCrossRef Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese American in Hawaii. N Engl J Med. 1991;325:1132–6.PubMedCrossRef
13.
Zurück zum Zitat Hirata Y, Maeda S, Mitsuno Y, Takeishi K, Yanai A, Akanuma M, et al. Helicobacter pylori CagA protein activates serum response element-driven transcription independently of tyrosine phosphorylation. Gastroenterology. 2002;123:1962–71.PubMedCrossRef Hirata Y, Maeda S, Mitsuno Y, Takeishi K, Yanai A, Akanuma M, et al. Helicobacter pylori CagA protein activates serum response element-driven transcription independently of tyrosine phosphorylation. Gastroenterology. 2002;123:1962–71.PubMedCrossRef
14.
Zurück zum Zitat Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52:6735–40.PubMed Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52:6735–40.PubMed
15.
Zurück zum Zitat Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784–9.PubMedCrossRef Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784–9.PubMedCrossRef
16.
Zurück zum Zitat Huang JQ, Scridhar S, Chen Y, Hung RH. Meta-analysis of the relationship between elicobacter pylori seropositivity and gastric cancer. Gastroenterology. 1998;114:1169–79.PubMedCrossRef Huang JQ, Scridhar S, Chen Y, Hung RH. Meta-analysis of the relationship between elicobacter pylori seropositivity and gastric cancer. Gastroenterology. 1998;114:1169–79.PubMedCrossRef
17.
Zurück zum Zitat Naylor GM, Gotoda T, Dixon M, Shimoda T, Gatta L, Owen R, et al. Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients. Gut. 2006;55:1545–52.PubMedCentralPubMedCrossRef Naylor GM, Gotoda T, Dixon M, Shimoda T, Gatta L, Owen R, et al. Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients. Gut. 2006;55:1545–52.PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology. 1982;83:204–9.PubMed Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology. 1982;83:204–9.PubMed
19.
Zurück zum Zitat Yoshihara M, Hiyama T, Yoshida S, Ito M, Tanaka S, Watanabe Y, et al. Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: a case-control study. Scand J Gastroenterol. 2007;42:760–4.PubMedCrossRef Yoshihara M, Hiyama T, Yoshida S, Ito M, Tanaka S, Watanabe Y, et al. Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: a case-control study. Scand J Gastroenterol. 2007;42:760–4.PubMedCrossRef
20.
Zurück zum Zitat Yamaji Y, Mitsushima T, Ikuma H, Okamoto M, Yoshida H, Kawabe T, et al. Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects. Gut. 2001;49:335–40.PubMedCentralPubMedCrossRef Yamaji Y, Mitsushima T, Ikuma H, Okamoto M, Yoshida H, Kawabe T, et al. Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects. Gut. 2001;49:335–40.PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Watabe H, Mitsushima T, Yamaji Y, Okamoto M, Wada R, Kokubo T, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut. 2005;54:764–8.PubMedCentralPubMedCrossRef Watabe H, Mitsushima T, Yamaji Y, Okamoto M, Wada R, Kokubo T, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut. 2005;54:764–8.PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Guidelines for standard method of stomach radiography (in Japanese). J Gastroenterol Mass Surv. 2002;40:437–447. Guidelines for standard method of stomach radiography (in Japanese). J Gastroenterol Mass Surv. 2002;40:437–447.
23.
Zurück zum Zitat Bhandari P, Green S, Hamanaka H, Nakajima T, Matsuda T, Saito Y, et al. Use of Gascon and Pronase either as apre-endoscopic drink or as targeted endoscopic flushes to improve visibility during gastroscopy: aprospective, randomized, controlled, blinded trial. Scand J Gastroenterol. 2010;45:357–61.PubMedCrossRef Bhandari P, Green S, Hamanaka H, Nakajima T, Matsuda T, Saito Y, et al. Use of Gascon and Pronase either as apre-endoscopic drink or as targeted endoscopic flushes to improve visibility during gastroscopy: aprospective, randomized, controlled, blinded trial. Scand J Gastroenterol. 2010;45:357–61.PubMedCrossRef
25.
Zurück zum Zitat Miki K, Ichinose M, Kakei N, Yahagi N, Matsushima M, Tsukada S, et al. The clinical application of the serum pepsinogen I and II levels as a mass screening method for gastric cancer. Adv Exp Med Biol. 1995;362:139–43.PubMedCrossRef Miki K, Ichinose M, Kakei N, Yahagi N, Matsushima M, Tsukada S, et al. The clinical application of the serum pepsinogen I and II levels as a mass screening method for gastric cancer. Adv Exp Med Biol. 1995;362:139–43.PubMedCrossRef
26.
Zurück zum Zitat Watanabe Y, Kurata JH, Mizuno S, Mukai M, Inokuchi H, Miki K, et al. Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan. Dig Dis Sci. 1997;42:1383–7.PubMedCrossRef Watanabe Y, Kurata JH, Mizuno S, Mukai M, Inokuchi H, Miki K, et al. Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan. Dig Dis Sci. 1997;42:1383–7.PubMedCrossRef
27.
Zurück zum Zitat Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, Goh KL, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008;9:279–87.PubMedCrossRef Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, Goh KL, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008;9:279–87.PubMedCrossRef
29.
Zurück zum Zitat Wittes RE, Friedman MA. Accrual to clinical trials. J Natl Cancer Inst. 1988;80:884–5. Wittes RE, Friedman MA. Accrual to clinical trials. J Natl Cancer Inst. 1988;80:884–5.
30.
Zurück zum Zitat Kunisaki C, Ishino J, Nakajima S, Motohashi H, Akiyama H, Nomura M, et al. Outcomes of mass screening for gastric carcinoma. Ann Surg Oncol. 2006;13:221–8.PubMedCrossRef Kunisaki C, Ishino J, Nakajima S, Motohashi H, Akiyama H, Nomura M, et al. Outcomes of mass screening for gastric carcinoma. Ann Surg Oncol. 2006;13:221–8.PubMedCrossRef
31.
Zurück zum Zitat Foundation for Promotion of Cancer Research. Cancer statistics in Japan—2012. Tokyo, Japan. Foundation for Promotion of Cancer Research. Cancer statistics in Japan—2012. Tokyo, Japan.
32.
Zurück zum Zitat Suzuki H, Gotoda T, Sasako M, Saito D. Detection of early gastric cancer: misunderstanding the role of mass screening. Gastric Cancer. 2006;9:315–9.PubMedCrossRef Suzuki H, Gotoda T, Sasako M, Saito D. Detection of early gastric cancer: misunderstanding the role of mass screening. Gastric Cancer. 2006;9:315–9.PubMedCrossRef
33.
Zurück zum Zitat Tashiro A, Sano M, Kinameri K, Fujita K, Takeuchi Y. Comparing mass screening techniques for gastric cancer in Japan. World J Gastroenterol. 2006;12:4874–5. Tashiro A, Sano M, Kinameri K, Fujita K, Takeuchi Y. Comparing mass screening techniques for gastric cancer in Japan. World J Gastroenterol. 2006;12:4874–5.
34.
Zurück zum Zitat Dan YY, So JB, Yeoh KG. Endoscopic screening for gastric cancer. Clin Gastroenterol Hepatol. 2006;4:709–16.PubMedCrossRef Dan YY, So JB, Yeoh KG. Endoscopic screening for gastric cancer. Clin Gastroenterol Hepatol. 2006;4:709–16.PubMedCrossRef
35.
Zurück zum Zitat Riecken B, Pfeiffer R, Ma JL, Jin ML, Li JY, Liu WD, et al. No impact of repeated endoscopic screening on gastric cancer mortality in a prospectively followed Chinese population at high risk. Prev Med. 2002;34:22–8.PubMedCrossRef Riecken B, Pfeiffer R, Ma JL, Jin ML, Li JY, Liu WD, et al. No impact of repeated endoscopic screening on gastric cancer mortality in a prospectively followed Chinese population at high risk. Prev Med. 2002;34:22–8.PubMedCrossRef
36.
Zurück zum Zitat Choi IJ. Screening and surveillance of gastric cancer. Korean J Gastroenterol. 2007;49(suppl):15–22. Choi IJ. Screening and surveillance of gastric cancer. Korean J Gastroenterol. 2007;49(suppl):15–22.
37.
Zurück zum Zitat Goh KL, Cheah PL, Md N, Quek KF, Parasakthi N. Ethnicity and H. pylori as risk factors for gastric cancer in Malaysia: a prospective case control study. Am J Gastroenterol. 2007;102:40–5.PubMedCrossRef Goh KL, Cheah PL, Md N, Quek KF, Parasakthi N. Ethnicity and H. pylori as risk factors for gastric cancer in Malaysia: a prospective case control study. Am J Gastroenterol. 2007;102:40–5.PubMedCrossRef
Metadaten
Titel
Randomized controlled trial comparing gastric cancer screening by gastrointestinal X-ray with serology for Helicobacter pylori and pepsinogens followed by gastrointestinal endoscopy
verfasst von
Takuji Gotoda
Hideki Ishikawa
Hirohide Ohnishi
Kentaro Sugano
Chika Kusano
Chizu Yokoi
Yutaka Matsuyama
Fuminori Moriyasu
Publikationsdatum
01.07.2015
Verlag
Springer Japan
Erschienen in
Gastric Cancer / Ausgabe 3/2015
Print ISSN: 1436-3291
Elektronische ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-014-0408-5

Weitere Artikel der Ausgabe 3/2015

Gastric Cancer 3/2015 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.